Addis Ababa University Libraries Electronic Thesis and Dissertations: AAU-ETD! >
College of Health Sciences >
Thesis - Public Health >
Please use this identifier to cite or link to this item:
|Title: ||Hematological profile of HIV Infected Adult Individuals After Receiving Highly Active Antiretroviral Therapy (HAART) at Black Lion Specialized Hospital, Addis Ababa Ethiopia|
|Authors: ||Jemal, Alemu|
|Advisors: ||Aster Tsegaye (MSc, PhD)|
Wondwossen Amogne (MD, Internist)
Bineyam Taye (BSc, MPH)
Asaye Birhanu ( BSc,MSc)
|Copyright: ||Jun-2011 |
|Date Added: ||11-May-2012 |
Background: -Treatment of HIV infected patients with Highly Active Antiretroviral Therapy (HAART) leads to immune reconstitution as shown by increase in CD4+ lymphocyte counts, decreased risk of opportunistic infection and improve survival, however, little is known about its impact on hematological parameters in resource limited settings like Ethiopia.
Objective: -To assess hematological profile among adult HIV infected individuals at the baseline and six month after initiation of Highly Active Antiretroviral Therapy.
Methods: -Retrospective cohort study was conducted among HIV infected adult patients who attended ART clinic and received HAART between September 2005 and August 2010 at ART clinic of Black Lion Specialized Hospital Addis Ababa, Ethiopia. A total of 379 subjects were selected based on convenience sampling. Demographic, clinical and hematological (WBC, CD4+ T cells, Hgb and Platelets) data were collected between July and August 2010 carefully from the existing ART logbook and patient follow up cards accordingly.Selected hematological abnormalities were defined as leucopenia, thrombocytopenia, severe thrombocytopenia, anemia and immunodeficiency. Data collected through a standardized questionnaire were entered into Excel spread sheet and transported into and analyzed by SPSS Version 15.0 soft ware (SPSS INC, Chicago, IL, USA).Median change of different hematological values during follow up time between consecutive visits and each follow up from the base line were compared using Wilcoxon signed rank test.
Results: -At the baseline 379 subjects who started ART from September 2005 to August 2010 were included in the study; 240 of the patients were females. The subjects studied had a baseline CD4+ T cells count ranging from 4-573 cells/ul, median 111 cells/uL IQR (72-176). 329 (86.8%) of the study subjects were having CD4 + T cell count below 200 cells/ul and CD4+ T cell count of<50 cells/ul was seen in 69(18.2%) patients. Moreover, 25 (9.5 %) of the patients were leucopenic, 104 (43.3 %) of females and 60(43.2%) of males were anemic while 60(15.8 %) of the total 379 patients were thrombocytopenic. After six month initiation of HAART, the median CD4+ T cell count was 190 cells/uL IQR (128-278), thrombocytopenia was seen only in 25(6.6%) of the patients and 25 (6.6 %) were leucopenic. The prevalence of anemia was only 22.7 % and 18.8 % in females and males respectively.
Conclusion: -HAART improved CD4+T cell count, Hgb, white blood cells and platelet count of HIV infected individuals. The difference in hematological parameters between baseline and after 6 month initiation of HAART was statistically significant (P< 0.05).|
|Appears in:||Thesis - Public Health|
Items in the AAUL Digital Library are protected by copyright, with all rights reserved, unless otherwise indicated.